Ledger.Open graph →

SEC Form D · filed February 22, 2024

CoRegen, Inc

Offering

—

Sold

$14.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

ASPEN, CO

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

David C. Lonard, Phd · Aspen, COExec David M. Cornell, Ii · Aspen, CODirector Edward J. Benz, Jr · Aspen, CODirector John C. Thomas, Jr · Aspen, COExec Steve C. Gorlin · Aspen, COExec · Director Clifford C. Dasco, M.D · Aspen, CODirector Clifford C. Dasco, M.D · Aspen, CODirector Steve C. Gorlin · Aspen, COExec · Director John C. Thomas, Jr · Aspen, COExec Edward J. Benz, Jr · Aspen, CODirector David M. Cornell, Ii · Aspen, CODirector David C. Lonard, Phd · Aspen, COExec Bert W. O'Malley, M.D · Aspen, CODirector Remy Ruiz · Mill Valley, CADirector Baruch E. Gross · Brooklyn, NYExec · Director Paras Malde · George Town, Grand Cayman, Cayman IslandsDirector Paras Malde · George Town, Grand Cayman, Cayman IslandsExec Kevin Mein · Lafayette, CADirector Lauren Taylor Wolfe · New York, NYExec Bert W. O'Malley, M.D · Aspen, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗